|
Change of Director's Interest Notice - David Trimboli
|
22 June 2023 at 10:05am
|
|
Change of Director's Interest Notice - Chris Ntoumenopoulos
|
22 June 2023 at 10:05am
|
|
Notification regarding unquoted securities - MEB
|
22 June 2023 at 9:55am
|
|
Application for quotation of securities - MEB
|
22 June 2023 at 9:55am
|
|
Notification of cessation of securities - MEB
|
19 June 2023 at 8:55am
|
|
Notification regarding unquoted securities - MEB
|
30 May 2023 at 8:40am
|
|
Application for quotation of securities - MEB
|
29 May 2023 at 12:05pm
|
|
Medibio Completes Share Purchase Plan
|
29 May 2023 at 12:05pm
|
|
Results of Extraordinary General Meeting
|
23 May 2023 at 12:20pm
|
|
Investor Presentation - May 2023
|
18 May 2023 at 3:40pm
|
|
Change in Venue and Time for Extraordinary General Meeting
|
1 May 2023 at 5:30pm
|
|
March 2023 Quarterly Activities Report and Appendix 4C
|
27 April 2023 at 8:40am
|
|
Letter to Shareholders & Notice of EGM & Proxy Form
|
21 April 2023 at 3:25pm
|
|
MEB Executes Bridging Loans with Directors
|
21 April 2023 at 2:50pm
|
|
Initial Director's Interest Notice - Thomas Young
|
17 April 2023 at 10:05am
|
|
Share Purchase Plan Supplementary Prospectus
|
14 April 2023 at 4:30pm
|
|
Final Director's Interest Notice
|
12 April 2023 at 5:40pm
|
|
Board & Managment Changes & Change of Offices
|
12 April 2023 at 10:05am
|
|
Update on Share Purchase Plan Timetable
|
6 April 2023 at 3:25pm
|
|
Appendix 3Z
|
16 March 2023 at 4:50pm
|
|
Resignation of Non-Executive Director
|
16 March 2023 at 4:45pm
|
|
Share Purchase Plan Prospectus
|
2 March 2023 at 9:50am
|
|
Medibio Lodges Breakthrough Device Designation with FDA
|
27 February 2023 at 10:15am
|
|
Update to Share Purchase Plan Timetable
|
24 February 2023 at 4:40pm
|
|
Half Yearly Report and Accounts
|
24 February 2023 at 4:30pm
|
|
Change in substantial holding
|
23 February 2023 at 2:35pm
|
|
708A Cleansing Notice
|
23 February 2023 at 2:25pm
|
|
Application for quotation of securities - MEB
|
21 February 2023 at 10:25am
|
|
Update to Share Purchase Plan Timetable
|
20 February 2023 at 3:20pm
|
|
Appendix 3X
|
17 February 2023 at 11:10am
|
|
Proposed issue of securities - MEB
|
15 February 2023 at 10:25am
|
|
MEB to Raise up to $2.75 million By Way of a Placement & SPP
|
15 February 2023 at 10:25am
|
|
Medibio Appoints Non-Executive Director to the Board
|
15 February 2023 at 9:35am
|
|
Trading Halt
|
10 February 2023 at 5:50pm
|
|
Medibio Quarterly Update and Cashflow Report
|
31 January 2023 at 9:55am
|
|
Notification of cessation of securities - MEB
|
4 January 2023 at 5:05pm
|
|
Medibio Receives R&D Tax Incentive Refund
|
15 November 2022 at 8:50am
|
|
Appendix 3Z
|
11 November 2022 at 1:20pm
|
|
Results of Annual General Meeting
|
11 November 2022 at 1:20pm
|
|
CEO Presentation to 2022 AGM
|
11 November 2022 at 8:55am
|
|
Chair's Address to the 2022 Annual General Meeting
|
11 November 2022 at 8:50am
|
|
Resignation of Director and Resolution Withdrawal
|
11 November 2022 at 8:45am
|
|
Medibio Quarterly Update and Cashflow Report
|
31 October 2022 at 6:15pm
|
|
Medibio Announces Appointment of Non-Executive Chair
|
26 October 2022 at 10:30am
|
|
Notice of Annual General Meeting/Proxy Form
|
10 October 2022 at 10:10am
|
|
Appendix 4G and Corporate Governance Statement
|
30 September 2022 at 5:25pm
|
|
2022 Annual Report
|
30 September 2022 at 5:25pm
|
|
Director Nomination Closing Date for AGM
|
21 September 2022 at 5:55pm
|
|
Medibio Appoints CEO
|
19 September 2022 at 10:25am
|
|
Initial Directors Interest Notice
|
6 September 2022 at 10:30am
|
Medibio